Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
J Hematol Oncol
; 16(1): 42, 2023 04 29.
Article
in En
| MEDLINE
| ID: mdl-37120593
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Leukemia, Myeloid, Acute
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
China